Aerie Pharma (AERI) Announces Submission of Rhopressa NDA to FDA for IOP
Tweet Send to a Friend
Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
